Biotechnology

Dr. Song works with organ-on-chip systems and leads investigations on artificial implantable organs through engineering approaches and biomaterials that manipulate cell behavior. Her work has helped applications in neural regeneration, muscle rehabilitation, diabetes treatment, and bone tissue engineering. Her goals are to contribute to the fundamental scientific knowledge at the intersection of biology, engineering, and medicine. She aspires to advance new diagnostics and therapeutics that better serve the patients in need, help the physicians, as well as improve the public health outcome. Dr. Song completed her PhD from University of California Berkeley (UC Berkeley) and University of California San Francisco (UCSF). She received her postdoctoral training on neural repair and neuromuscular recovery techniques through electrical stimulation on stem cell functions at Stanford University. Dr. Song obtained her BS with honors in biomedical engineering from Brown University. Dr. Song is the recipient of multiple academic awards and fellowships from the National Institute of Health Ruth L. Kirschstein Research Service Awards (NIH NRSA F32), the National Science Foundation Graduate Research Fellowship (NSF GRFP), Forbes Magazine 30 Under 30, Gates Millennium Foundation, amongst many others.

The Horton lab uses a variety of biochemical and biophysical methods to investigate DNA binding proteins. Recent projects include the discovery of a novel mechanism of regulation of enzyme activity using filamentation. Filamentation, or self-association into polymers of varied lengths, by enzymes has only recently been appreciated as a widespread phenomenon, although the purpose of filamentation is not known in most cases. We discovered this phenomenon in 2010 in a sequence specific endonuclease, SgrAI, and have now determined its high resolution structure via cryo-electron microscopy. We have also performed a full kinetic analysis showing that filamentation greatly expedites the activation of the enzyme, and also allows for the sequestration of enzyme activity onto only a subset of available substrates. The other major project in the lab concerns the triggering of autoimmune diseases in genetically susceptible individuals. We study proteins from the human parvovirus B19, a virus which often precedes the development of autoimmune diseases like rheumatoid arthritis, autoimmune hepatitis, and lupus. We study how these proteins interact with cellular components to modulate the immune system into loss of self-tolerance.

We are a plant genomics lab who specialize in whole genome sequencing and assembly; with analyses of structural variation, gene modeling and transcriptomes. Our work on major projects of rice, corn, barley, etc, allows us to share our technical expertise with other researchers. Our research in plant and animal genomes, at the whole genome and transcriptome levels, will impact successful genetic selections toward the goal of feeding the 9 billion people toward the year 2050. Keywords: "Genome Sequencing", "PacBio", "Structural Genomics", "Plant Genetics", "DNA Extraction"

Dr. Yitshak Zohar Ph.D., is Professor of Aerospace-Mechanical Engineering, Biomedical Engineering and the BIO5 Institute. He received a B.S. and M.S. from Technion-Israel Institute of Technology and a Ph.D. at the University of Southern California. Dr. Zohar was honored with the Fellow - The American Society of Mechanical Engineers (ASME) in 2003; and in 2007, the University of Arizona Technology Innovation Award. Dr. Zohar's research interests are in understand the process of Cell Receptor and Surface Ligand density effects in dynamic states of adhering circulating tumor cells and the creation of a high performance microsystem for isolating circulating tumor cells. With this mission, Dr. Zohar focuses on the development of micro/nanotechnology and fabrication of microfluidic devices for biochemical/medical applications. He has developed novel surface-chemistry techniques that enable selective manipulation of surface properties of fluidic microchannels and nanoparticles. Further developing in ‘smart’ nanoparticles, with encapsulated anti-cancer drug in their core and targeting ligands on their surface, designed to specifically destroy CTCs in vivo in effort to eradicate the cancer disease is taking place. Other work being performed by the Zohar laboratory includes the controlled dissociation of fresh brain tissue into viable neurons suitable for subsequent cell culture utilizing microfluidic systems; the investigation of pollen-tube/ovule interaction, particularly the attraction and repulsion signaling processes, using a microchannel-based assay; and protein-fiber formation in microfluidic devices.

Rod Wing, PhD, and his lab, The Arizona Genomics Institute, specialize in building what geneticists call a physical map of a genome- a crucial foundation of any genome sequencing effort. AGI has earned a reputation for providing extremely high-quality maps, as documented in previous sequencing efforts leading to the genome sequences of rice and corn. The genome sequence will allow scientists to locate and identify genes that can improve and strengthen crops and increase yield in order to help solve the Earth’s looming food crisis by creating new strains of the cereal crops that make up 60% of humankind’s diet. Keywords: Genome Biology, Genome Sequencing/Assembly/Annotation, Food Security, Rice

We study control of cell fate and self-organization in intestinal renewal and drug response in cancer. Utilizing the fascinating characteristics of intestinal stem cells combined with chemical biology and computational image analysis approaches, we are addressing fundamental questions of multicellular systems: How do cells identify, measure, and respond to each other and to their environment? What are the signals that control the renewal and regeneration of tissues? How do these signals become defective in colorectal cancer? Our long-term goal is to uncover an underlying circuit theory behind these behaviors – a set of predictive principles that tell us how complex functionality arises from simpler biological components. We have a particular interest in kinase networks that regulate healthy tissue homeostasis and become damaged in cancer. Through our quantitative high-throughput imaging and drug discovery efforts, we are finding new ways to understand and repair these networks. Keywords: Stem cells, Cancer, Regeneration, Drug discovery

Plants grow as a result of the proliferation of stem cells and the establishment and maintenance of defined developmental fates in progeny cells. Our major goal is to elucidate general molecular mechanisms used by plants to specify and maintain cell fates, ranging from stem cells to fully differentiated cell types. Both experimental manipulations and the identification of genes responsible for the maintenance of stem cells and for the establishment and maintenance of differentiated cell fates through forward genetic screens implicate intercellular signaling in these processes. Because of the important role of intercellular signaling in the differentiation of cells initiating from meristems, studying receptors is one way to dissect these molecular mechanisms. To understand signaling events that take place in development, we analyze the phenotypes of plants mutant for individual or multiple receptors. My lab has identified key roles for specific receptors during radial patterning in early embryogenesis (Nodine et al., 2007), during the formation of lateral roots (Wierzba and Tax, in preparation), in the formation of fruit organs from stem cells within the fruit (Durbak and Tax, 2011), in the development of vascular tissues (Bryan et al., 2012), and in the process of cell elongation (Li et al., 2002). Future studies will include further analysis of the signaling networks anchored by these receptors, with a specific focus on the transitions between different downstream transcription factor targets. In addition, we are interested in developing approaches to isolate mutants in these receptors to manipulate the architecture and physiological responses of crop plants.

My research interests relate to the theoretical chemistry and biophysics of complex systems. Current areas of funded research include the study of protein dynamics in enzymatic reactions, quantum tunneling in enzymatic reactions, modeling of the cardiac thin filament with application to disease mechanism, and the study of the properties of micelles created from green surfactants. I am chair elect of the biological physics division of the American Physical Society, a Fellow of the APS and the AAAS.

Monica Schmidt is an Associate Professor in the School of Plant Sciences in the College of Agricultural and Life Sciences at the University of Arizona. Dr. Schmidt’s research interests are in both functional foods and functional genomics. Her research aims at applying molecular biology and genetic techniques to help alleviate current major agricultural problems. As soybean is a global commodity, much of her research focuses on soybean seed traits. Current research is investigating cellular mechanisms to strengthen the metabolic engineering efforts to fortify crops with nutraceutical carotenoids. Since soybean oil is a large component of the American diet, Dr. Schmidt is also investigating means to engineer a more healthy oil composition. Other functional food projects aim at the suppression of deleterious compounds in crops, such as toxins produced from contaminating fungus, in maize and peanuts. She uses techniques of plant biotechnology in over a dozen crops to investigate gene function, at a cellular and entire plant level. Dr. Schmidt has worked with both domestic and international collaborators on value-added traits in seeds of legumes for over a decade and is one of the few academic laboratories that can routinely transform soybean. She has been involved with a number of innovations in tissue culture / transformation techniques (for example, maturation media for soybean, novel gene expression cassette system) and her research on seed manipulation has resulted in a start-up company and patents. Keywords: plant biotechnology, functional foods, soybean, maize

Marek Romanowski, PhD, and his work on translating physics into medical products have huge implications for the evolution of personalized medicine. On cue, a tiny pillbox of gold floating in your bloodstream can deliver its medicine exactly to the right cell, one that is sick with cancer, avoiding all of your healthy cells. A gold capsule – about 50 to 200 nanometers in diameter, large enough to do the work of transporting a few molecules of medicine and respond to light signals – is too large to pass out through the kidneys. But on command by an enzyme, it can fall apart into pieces smaller than 10 nanometers, just a few molecules. The new size can easily leave our bodies at no risk. The gold pillbox has many other possible applications. In addition to delivering a drug, it can become a part of a diagnostic test, or deliver genetic material to a cell to permanently modify the cells’ DNA—a key step in gene therapy.